Amgen (NASDAQ: AMGN) today announced the launch of AmgenNow, a new direct-to-patient program starting with Repatha® (evolucumab). This follows landmark results demonstrating Repatha significantly ...
Cybercriminals ramp up fraudulent tax tools as taxpayers increasingly file online in 2025 IRVINE, CALIFORNIA / ACCESS ...
The LGBTQ+ Victory Institute is seeing its highest demand ever for political training among transgender candidates.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback